CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Nirali N. Shah, Dina Schneider et al.|Blood|2022Cited by 179
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cellsAdam J. Lamble, Nirali N. Shah, Regina M. Myers et al.|Blood Advances|2022Cited by 149
Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Nirali N. Shah, Bonnie Yates et al.|Blood Advances|2025Cited by 5
Initial Experience with CD19/CD22 BiCistronic CAR T-Cells in Children and Young Adults with Recurrent or Refractory B-Cell MalignanciesBrynn B. Duncan, Nirali N. Shah, Sara Silbert et al.|Blood|2024Cited by 4
Prospective Study Utilizing PET-CT and Next-Generation Sequencing to Evaluate for Peri-CAR T-Cell Non-CNS Extramedullary Disease in B-Acute Lymphoblastic LeukemiaBrynn B. Duncan, Nirali N. Shah, Alexander W. Rankin et al.|Transplantation and Cellular Therapy|2025Cited by 0